Overview Study of AT-752 in Healthy Subjects Status: Recruiting Trial end date: 2021-10-01 Target enrollment: Participant gender: Summary This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-752 in healthy subjects Phase: Phase 1 Details Lead Sponsor: Atea Pharmaceuticals, Inc.